2011
Integration of Antiretroviral Therapy with Tuberculosis Treatment
Abdool Karim S, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray AL, Gengiah T, Gengiah S, Naidoo A, Jithoo N, Nair G, El-Sadr WM, Friedland G, Abdool Karim Q. Integration of Antiretroviral Therapy with Tuberculosis Treatment. New England Journal Of Medicine 2011, 365: 1492-1501. PMID: 22010915, PMCID: PMC3233684, DOI: 10.1056/nejmoa1014181.Peer-Reviewed Original ResearchConceptsImmune reconstitution inflammatory syndromeT-cell countsEarly ART groupLater-ART groupInitiation of ARTAntiretroviral therapyTuberculosis treatmentIncidence rateCubic millimeterAdverse eventsRisk of IRISHuman immunodeficiency virus (HIV) infectionReconstitution inflammatory syndromeMedian viral loadImmunodeficiency virus infectionAIDS-free survivalRisk of AIDSHigher CD4Median CD4Inflammatory syndromeAmbulatory patientsImmunodeficiency syndromeViral loadContinuation phaseAntiretroviral drugs
1983
Acquired Immunodeficiency Syndrome Ophthalmic Manifestations in Ambulatory Patients
Rosenberg P, Uliss A, Friedland G, Harris C, Small C, Klein R. Acquired Immunodeficiency Syndrome Ophthalmic Manifestations in Ambulatory Patients. Ophthalmology 1983, 90: 874-878. PMID: 6314220, DOI: 10.1016/s0161-6420(83)80010-4.Peer-Reviewed Original ResearchConceptsAmbulatory patientsIntravenous drug abuseCotton wool spotsEpidemiology of AIDSCytomegalovirus retinitisOcular findingsOcular involvementOphthalmic manifestationsImmunodeficiency syndromePatientsMajor manifestationsDrug abuseManifestationsRetinitisSyndromeOphthalmologistsEpidemiologyAIDSFindings